179 related articles for article (PubMed ID: 31654891)
1. Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics.
Casale TB; Aalbers R; Bleecker ER; Meltzer EO; Zaremba-Pechmann L; de la Hoz A; Kerstjens HAM
Respir Med; 2019; 158():97-109. PubMed ID: 31654891
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.
Paggiaro P; Halpin DM; Buhl R; Engel M; Zubek VB; Blahova Z; Moroni-Zentgraf P; Pizzichini E
J Allergy Clin Immunol Pract; 2016; 4(1):104-13.e2. PubMed ID: 26563670
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
Kerstjens HA; Moroni-Zentgraf P; Tashkin DP; Dahl R; Paggiaro P; Vandewalker M; Schmidt H; Engel M; Bateman ED
Respir Med; 2016 Aug; 117():198-206. PubMed ID: 27492532
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
Ohta K; Ichinose M; Tohda Y; Engel M; Moroni-Zentgraf P; Kunimitsu S; Sakamoto W; Adachi M
PLoS One; 2015; 10(4):e0124109. PubMed ID: 25894430
[TBL] [Abstract][Full Text] [Related]
5. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.
Beeh KM; Moroni-Zentgraf P; Ablinger O; Hollaenderova Z; Unseld A; Engel M; Korn S
Respir Res; 2014 Jun; 15(1):61. PubMed ID: 24890738
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
Dahl R; Engel M; Dusser D; Halpin D; Kerstjens HAM; Zaremba-Pechmann L; Moroni-Zentgraf P; Busse WW; Bateman ED
Respir Med; 2016 Sep; 118():102-111. PubMed ID: 27578478
[TBL] [Abstract][Full Text] [Related]
8. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
Vogelberg C; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Hamelmann E; Engel M; Szefler S
Respir Res; 2015 Feb; 16(1):20. PubMed ID: 25851298
[TBL] [Abstract][Full Text] [Related]
9. Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.
Casale TB; Bateman ED; Vandewalker M; Virchow JC; Schmidt H; Engel M; Moroni-Zentgraf P; Kerstjens HAM
J Allergy Clin Immunol Pract; 2018; 6(3):923-935.e9. PubMed ID: 29174062
[TBL] [Abstract][Full Text] [Related]
10. Safety of tiotropium Respimat
Graham LM; Kerstjens HAM; Vogelberg C; Hamelmann E; Szefler SJ; Pisternick-Ruf W; Engel M; El Azzi G; Unseld A; Foggs MB
Respir Med; 2019 Aug; 155():58-60. PubMed ID: 31302579
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.
Kerstjens HA; Casale TB; Bleecker ER; Meltzer EO; Pizzichini E; Schmidt O; Engel M; Bour L; Verkleij CB; Moroni-Zentgraf P; Bateman ED
Lancet Respir Med; 2015 May; 3(5):367-76. PubMed ID: 25682232
[TBL] [Abstract][Full Text] [Related]
12. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
Szefler SJ; Murphy K; Harper T; Boner A; Laki I; Engel M; El Azzi G; Moroni-Zentgraf P; Finnigan H; Hamelmann E
J Allergy Clin Immunol; 2017 Nov; 140(5):1277-1287. PubMed ID: 28189771
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
Hamelmann E; Bernstein JA; Vandewalker M; Moroni-Zentgraf P; Verri D; Unseld A; Engel M; Boner AL
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 27811070
[TBL] [Abstract][Full Text] [Related]
14. Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial.
Hamelmann E; Bateman ED; Vogelberg C; Szefler SJ; Vandewalker M; Moroni-Zentgraf P; Avis M; Unseld A; Engel M; Boner AL
J Allergy Clin Immunol; 2016 Aug; 138(2):441-450.e8. PubMed ID: 26960245
[TBL] [Abstract][Full Text] [Related]
15. Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype.
Szefler SJ; Vogelberg C; Bernstein JA; Goldstein S; Mansfield L; Zaremba-Pechmann L; Engel M; Hamelmann E
J Allergy Clin Immunol Pract; 2019; 7(7):2286-2295.e4. PubMed ID: 30922990
[TBL] [Abstract][Full Text] [Related]
16. Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis.
Wang L; Zhou R; Xie X
J Asthma; 2019 Jan; 56(1):69-78. PubMed ID: 29420077
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
Buhl R; FitzGerald JM; Meltzer EO; de la Hoz A; Sigmund R; Kerstjens HAM; Bleecker ER
Pulm Pharmacol Ther; 2020 Feb; 60():101881. PubMed ID: 31874283
[TBL] [Abstract][Full Text] [Related]
18. A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
Meltzer EO; Berger WE
Allergy Asthma Proc; 2018 Jan; 39(1):14-26. PubMed ID: 29279056
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study.
Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M
Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651
[TBL] [Abstract][Full Text] [Related]
20. Burden of Asthma and Role of 2.5 µg Tiotropium Respimat
Mansfield L; Duong-Quy S; Craig T
Adv Ther; 2019 Oct; 36(10):2587-2599. PubMed ID: 31435830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]